On June 18, 2025, the Society for Immunotherapy of Cancer (SITC) in partnership with the National Cancer Institute (NCI) held the fourth computational immuno-oncology webinar of series 5. The webinar was structured in three parts: (1) An overview of the current landscape of immune-related adverse events (irAEs) associated with immune checkpoint inhibitor therapy; (2) a review of the progress made to date in identifying and defining biomarkers for irAEs; (3) a presentation by Dr. Villani on methodologies developed in her laboratory at Massachusetts General Hospital aimed at identifying non-invasive biomarkers of irAEs. The session concluded with a discussion of ongoing challenges and future directions in the field.
View the webinar for free on-demand HERE.